T0	Participants 57 121	a report on 218 patients with a median follow-up of eight years.
T1	Participants 276 408	patients with advanced stage Hodgkin's disease (HD), as well as in early stage patients with systemic symptoms and/or bulky disease.
T2	Participants 428 552	218 patients with previously untreated HD entered this study: 106 patients in arm A (ABVD/MOPP) and 112 in arm B (ABVD/OPP).
T3	Participants 1105 1144	patients who entered the ABVD/MOPP arm.